237 related articles for article (PubMed ID: 1888834)
1. Idiopathic gastric acid hypersecretion: treatment implications for refractory acid/peptic disorders.
Lewis JH
Aliment Pharmacol Ther; 1991; 5 Suppl 1():15-24. PubMed ID: 1888834
[TBL] [Abstract][Full Text] [Related]
2. Long-term treatment with lansoprazole of patients with duodenal ulcer and basal acid output of more than 15 mmol/h.
Hirschowitz BI; Mohnen J; Shaw S
Aliment Pharmacol Ther; 1996 Aug; 10(4):497-506. PubMed ID: 8853753
[TBL] [Abstract][Full Text] [Related]
3. Is there any acid peptic disease that is refractory to proton pump inhibitors?
Bardhan KD
Aliment Pharmacol Ther; 1993; 7 Suppl 1():13-24, discussion 29-31. PubMed ID: 8490075
[TBL] [Abstract][Full Text] [Related]
4. Pantoprazole. A review of its pharmacological properties and therapeutic use in acid-related disorders.
Fitton A; Wiseman L
Drugs; 1996 Mar; 51(3):460-82. PubMed ID: 8882382
[TBL] [Abstract][Full Text] [Related]
5. Omeprazole. An update of its pharmacology and therapeutic use in acid-related disorders.
Wilde MI; McTavish D
Drugs; 1994 Jul; 48(1):91-132. PubMed ID: 7525198
[TBL] [Abstract][Full Text] [Related]
6. Omeprazole. A review of its use in Helicobacter pylori infection, gastro-oesophageal reflux disease and peptic ulcers induced by nonsteroidal anti-inflammatory drugs.
Langtry HD; Wilde MI
Drugs; 1998 Sep; 56(3):447-86. PubMed ID: 9777317
[TBL] [Abstract][Full Text] [Related]
7. Omeprazole. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peptic ulcer disease and Zollinger-Ellison syndrome.
Clissold SP; Campoli-Richards DM
Drugs; 1986 Jul; 32(1):15-47. PubMed ID: 3527658
[TBL] [Abstract][Full Text] [Related]
8. Gastric acid hypersecretion in refractory gastroesophageal reflux disease.
Collen MJ; Lewis JH; Benjamin SB
Gastroenterology; 1990 Mar; 98(3):654-61. PubMed ID: 2298369
[TBL] [Abstract][Full Text] [Related]
9. Comparison of omeprazole and ranitidine in treatment of refractory gastroesophageal reflux disease in patients with gastric acid hypersecretion.
Collen MJ; Strong RM
Dig Dis Sci; 1992 Jun; 37(6):897-903. PubMed ID: 1587194
[TBL] [Abstract][Full Text] [Related]
10. Rabeprazole: an update of its use in acid-related disorders.
Carswell CI; Goa KL
Drugs; 2001; 61(15):2327-56. PubMed ID: 11772142
[TBL] [Abstract][Full Text] [Related]
11. Lansoprazole. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy in acid-related disorders.
Spencer CM; Faulds D
Drugs; 1994 Sep; 48(3):404-30. PubMed ID: 7527761
[TBL] [Abstract][Full Text] [Related]
12. Role of acid suppressants in patients with Zollinger-Ellison syndrome.
Maton PN
Aliment Pharmacol Ther; 1991; 5 Suppl 1():25-35. PubMed ID: 1679671
[TBL] [Abstract][Full Text] [Related]
13. Esomeprazole: a review of its use in the management of gastric acid-related diseases in adults.
McKeage K; Blick SK; Croxtall JD; Lyseng-Williamson KA; Keating GM
Drugs; 2008; 68(11):1571-607. PubMed ID: 18627213
[TBL] [Abstract][Full Text] [Related]
14. Definition for idiopathic gastric acid hypersecretion. A statistical and functional evaluation.
Collen MJ; Sheridan MJ
Dig Dis Sci; 1991 Oct; 36(10):1371-6. PubMed ID: 1914757
[TBL] [Abstract][Full Text] [Related]
15. Rabeprazole: a review of its use in acid-related gastrointestinal disorders.
Langtry HD; Markham A
Drugs; 1999 Oct; 58(4):725-42. PubMed ID: 10551440
[TBL] [Abstract][Full Text] [Related]
16. Refractory duodenal ulcers (nonhealing duodenal ulcers with standard doses of antisecretory medication).
Collen MJ; Stanczak VJ; Ciarleglio CA
Dig Dis Sci; 1989 Feb; 34(2):233-7. PubMed ID: 2914544
[TBL] [Abstract][Full Text] [Related]
17. Omeprazole: a pharmacoeconomic evaluation of its use in duodenal ulcer and reflux oesophagitis.
Barradell LB; McTavish D
Pharmacoeconomics; 1993 Jun; 3(6):482-510. PubMed ID: 10146883
[TBL] [Abstract][Full Text] [Related]
18. Omeprazole. An updated review of its pharmacology and therapeutic use in acid-related disorders.
McTavish D; Buckley MM; Heel RC
Drugs; 1991 Jul; 42(1):138-70. PubMed ID: 1718683
[TBL] [Abstract][Full Text] [Related]
19. Basal acid output and gastric acid hypersecretion in gastroesophageal reflux disease. Correlation with ranitidine therapy.
Collen MJ; Johnson DA; Sheridan MJ
Dig Dis Sci; 1994 Feb; 39(2):410-7. PubMed ID: 8313826
[TBL] [Abstract][Full Text] [Related]
20. Clinical efficacy of pantoprazole compared with ranitidine.
Bader JP; Delchier JC
Aliment Pharmacol Ther; 1994; 8 Suppl 1():47-52. PubMed ID: 8180294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
